株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の心血管超音波システム市場:検査タイプ、技術、デバイスディスプレイ、エンドユーザー、地域別 - 成長率、市場動向、市場予測

Cardiovascular Ultrasound System Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 707339
出版日 ページ情報 英文 112 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
世界の心血管超音波システム市場:検査タイプ、技術、デバイスディスプレイ、エンドユーザー、地域別 - 成長率、市場動向、市場予測 Cardiovascular Ultrasound System Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年05月01日 ページ情報: 英文 112 Pages
概要

世界の心血管超音波システム市場は、2018年から2023年にかけて5.6%のCAGRで推移することが予測されています。近年の技術進歩と心臓手術実施件数の増加が当市場の主な成長要因となっています。

当レポートでは、世界の心血管超音波システム市場を調査し、市場の概要、検査タイプ・技術・デバイスディスプレイ・エンドユーザー・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 市場の定義

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な影響要因

第5章 市場概要

  • 現在の市場シナリオ
  • ファイブフォース分析
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係

第6章 成長要因、阻害要因、市場機会、課題(DROC)

  • 市場の成長要因
    • 心臓血管疾患(CVD)の罹患率の上昇
    • 技術的進歩
    • 侵襲的処置と比較した際の心エコー図検査の利点
  • 市場の阻害要因
    • 不利な償還シナリオ
    • 新技術導入における経済的影響
  • 市場機会
  • 主な課題

第7章 心血管超音波システム市場:セグメント別

  • 検査タイプ別
    • 経胸壁心エコー図検査
    • 経食道心エコー図検査
    • 運動負荷心エコー図検査
    • その他
  • 技術別
    • 2D
    • 3D・4D
    • ドップラーイメージング
  • デバイスディスプレイ別
    • カラー表示
    • モノクロ表示
  • エンドユーザー別
    • 病院・心臓病センター
    • 外来治療・在宅治療
    • 医療機器メーカー・製薬企業
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第8章 企業プロファイルと競合情勢

  • キヤノンメディカルシステムズ
  • Chison
  • Esaote SpA
  • GE Healthcare
  • 日立メディコ
  • KPI Healthcare Inc.
  • Philips Healthcare
  • Siemens Healthcare
  • Samsung Electronics Co., Ltd
  • Whale Imaging

第9章 市場の将来展望

目次
Product Code: 62805

Market Overview

The major factors for the growth of the cardiovascular ultrasound system market include the increasing incidence of cardiovascular diseases (CVDs), rise in technological advancements, and advantages of echocardiography over invasive cardiac diagnostic procedures.

Cardiovascular diseases (CVD) remain a substantial cause of morbidity and mortality in the developed world and is becoming an increasingly important cause of death in developing countries as well. An estimated 17.7 million people died from CVDs in 2015, representing 31% of all global deaths. Of these deaths, an estimated 7.4 million were due to coronary heart disease and 6.7 million were due to stroke. According to the American Heart Association (AHA), cardiovascular disease accounts for 17.3 million deaths per year. The Centre for Disease Control and Prevention states that about 610,000 people die of heart diseases in the United States every year, i.e., one in every four deaths can be attributed to CVDs. Coronary heart disease (CHD) is the most common type of heart disease, with a death toll of over 370,000 people, annually. CVD causes more than half of all the deaths across the European region. The Heart Foundation states that CVD is a major cause of death in Australia, with 45,053 deaths attributed to CVD in the country, in 2014. Consequently, the increase in the number of cardiovascular diseases has increased the demand for cardiovascular ultrasound system for the diagnosis.

Scope of the Report

As per the scope of this report, cardiovascular ultrasound systems use the ultrasound imaging technique to provide images of the heart. The market is segmented by test type, technology, device display, end-user, and geography.

Key Market Trends

2D Ultrasound Imaging is the Segment by Technology is expected to be the Fastest Growing Segment

2D ultrasound imaging is also known as B-mode echography or sonography. It displays a 2D map of B-mode data and is currently the most common form of cardiac ultrasound imaging used, worldwide. It uses multiple transducers. It enables the generation of multiple images of the field or frames every second on the screen, giving an illusion of movement. It is primarily used to measure cardiac chamber dimensions, assess valvular structure and function, and improve the accuracy of interpretation of Doppler modalities. 2D ultrasound is one of the most common forms of technology used. However, it has disadvantages, like low resolution, distortion of ultrasound wave resulting in inaccurate images, view of the internal bone structure, and regional placement. Moreover, technological advancements, like Doppler imaging and 3D/4D ultrasound imaging, are expected to affect the global 2D imaging market during the forecast period.

North America is Expected to Dominate the Market

The healthcare facilities in the country are of the highest standards, and are accessible to a large population, owing to favorable policies that make healthcare affordable by many. This helps in gaining a higher selling rate across the country. Coronary heart disease (CHD) is the most common type of heart disease. According to the American Heart Association (AHA), cardiovascular disease accounts for 17.3 million deaths per year. The increasing number of cardiac diseases, continuous advancements in the technology, high income of the citizens are some of the driving factors for the US cardiac ultrasound devices market. Rising chronic diseases prevalence is a prime reason for the increasing need and demand for these devices. The need to diagnose and monitor these diseases give rise to the demand, which can be fulfilled by the product manufacturer companies in the country. Because of the favorable factors, the market in the United States is expected to grow at a steady rate in the coming years.

Competitive Landscape

The market studied is a moderately consolidated market owing to the presence of many small and large market players. Some of the market players are Canon Medical Systems, Chison, Esaote SpA, GE Healthcare, Hitachi Medical Corporation, Koninklijke Philips NV, KPI Healthcare Inc., Samsung Healthcare, Siemens Healthcare, and Whale Imaging.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Cardiovascular Diseases (CVDs)
    • 4.2.2 Rise in Technological Advancements
    • 4.2.3 Advantages of Echocardiography over Invasive Cardiac Diagnostic Procedures
  • 4.3 Market Restraints
    • 4.3.1 Unfavorable Reimbursement Scenario
    • 4.3.2 Economic Impact of Adopting New Technologies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Test Type
    • 5.1.1 Transthoracic Echocardiogram
    • 5.1.2 Transesophageal Echocardiogram
    • 5.1.3 Stress Echocardiogram
    • 5.1.4 Other
  • 5.2 By Technology
    • 5.2.1 2D
    • 5.2.2 3D and 4D
    • 5.2.3 Doppler Imaging
  • 5.3 By Device Display
    • 5.3.1 Color Display
    • 5.3.2 Black and White (B/W) Display
  • 5.4 By End User
    • 5.4.1 Hospitals
    • 5.4.2 Ambulatory Centers
    • 5.4.3 Others
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 US
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 UK
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Canon Medical Systems
    • 6.1.2 Chison
    • 6.1.3 Esaote SpA
    • 6.1.4 GE Healthcare
    • 6.1.5 Hitachi Medical Corporation
    • 6.1.6 Koninklijke Philips NV
    • 6.1.7 KPI Healthcare Inc.
    • 6.1.8 Samsung Healthcare
    • 6.1.9 Siemens Healthcare GmbH
    • 6.1.10 Whale Imaging

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top